Investigators found that SMAD4 was critical in promoting CD8+ T cell function in both tumor and infection models.
[Science Advances]
Home Newsletters Immune Regulation News SMAD4, Activated by the TCR-Triggered MEK/ERK Signaling Pathway, Critically Regulates CD8+ T...
